6640--FY26| Thyroid Cancer Molecular Test| Orlando VA & San Juan| New Requirement
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
248-NETWORK CONTRACT OFFICE 8 (36C248)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36C24826Q0145
NAICS
621511 - Medical Laboratories
Classification Code
6640
Additional Details
The Department of Veterans Affairs, through its 248-Network Contract Office 8, has issued a combined synopsis/solicitation under procurement identifier 36C24826Q0145 for the provision of Thyroid Cancer Molecular Testing services. This requirement is intended to support both the Orlando VA Health Care System and the Caribbean Health Care System, reflecting the agency’s ongoing commitment to delivering advanced diagnostic capabilities to veterans in these regions.
The scope of this procurement centers on the acquisition of specialized molecular testing for thyroid cancer, a critical diagnostic service that aids in the accurate detection and management of thyroid malignancies. The intended outcome is to ensure timely and reliable laboratory results that inform clinical decision-making and enhance patient care for veterans served by the Orlando and San Juan facilities.
The solicitation falls under NAICS code 621511 (Medical Laboratories), indicating that the government seeks qualified laboratory service providers with expertise in molecular diagnostics, specifically those capable of performing advanced thyroid cancer assays. The Product Service Code (PSC) is 6640, further specifying the focus on laboratory equipment and supplies.
The place of performance for this contract is within the United States, with services to be rendered for the designated VA health care systems. The contracting activity is managed by the 248-Network Contract Office 8, a federal office within the Department of Veterans Affairs. The primary point of contact for this opportunity is Yolanda Glover, who can be reached at [email protected] or by phone at 352-548-4462.
It is important to note that, as per the latest amendment, this solicitation (36C24826Q0145) has been closed without an award being made. The notice explicitly states that another solicitation will be issued at a later date to fulfill this requirement. Contractors interested in this opportunity should monitor future postings for updates and new solicitation releases.
The procurement was posted on May 2, 2026, with an initial response deadline of June 3, 2026. The notice remains active on SAM.gov, and additional details, including attachments, are available via the provided opportunity link.
Contractors evaluating this opportunity should consider their capacity to deliver high-quality molecular laboratory testing services for thyroid cancer, their compliance with federal contracting requirements, and their ability to serve VA health care systems in multiple geographic locations. While set-aside requirements and special considerations are not specified in the current notice, interested parties should review future solicitations for such details.
In summary, this procurement represents a significant opportunity for medical laboratory service providers specializing in molecular diagnostics to support the Department of Veterans Affairs’ mission of delivering advanced healthcare services to veterans. Interested contractors are encouraged to stay informed of forthcoming solicitations related to this requirement.
Documents8